Chemicals · Founded 1986 · www.manalipetro.com · BSE 500268 · NSE MANALI PETRO · ISIN INE201A01024
No Notes Added Yet
Business
Manali Petrochemicals Ltd. (MPL) is an Indian chemical company primarily engaged in the manufacture of petrochemical products. Its core business involves the production of Propylene Glycol (PG) and Polyether Polyols. Propylene Glycol finds applications in pharmaceuticals, food, fragrance, cosmetics, and unsaturated polyester resins. Polyether Polyols are crucial raw materials for producing polyurethanes, which are used in various end-products like foams, coatings, adhesives, sealants, and elastomers for industries such as automotive, refrigeration, construction, and footwear. The company operates on a business-to-business (B2B) model, selling its manufactured chemicals to industrial customers across various sectors.
Revenue Mix
Manali Petrochemicals primarily derives its revenue from two main product categories:
Propylene Glycol (PG): Used in diverse applications from pharmaceuticals to industrial resins.
Polyether Polyols: Key ingredient for polyurethane products across various industries.
While specific percentage contributions are not consistently disclosed as separate reportable segments, these two product groups represent the vast majority of the company's manufacturing and sales activities. The company also produces ancillary products like Propylene Oxide.
Industry
Manali Petrochemicals operates in the Indian petrochemicals industry, specifically within the propylene derivatives segment. The industry is capital-intensive, cyclical, and heavily dependent on crude oil prices and the demand from end-user industries. Globally, the market for PG and Polyols is dominated by a few large players, but regionally, competition can be more fragmented. In India, Manali Petrochemicals is one of the leading domestic manufacturers of Propylene Glycol and Polyols, competing with other Indian players and imports from international producers. Its positioning is that of an established domestic producer with integrated facilities.
MOAT
Manali Petrochemicals possesses a moderate competitive advantage, primarily stemming from:
Established Market Position: Being one of the few significant domestic producers of PG and Polyols in India provides it with an established customer base and supply chain.
Operational Scale & Integration: Its manufacturing facilities offer some economies of scale and operational efficiencies in the Indian context, potentially leading to cost advantages over smaller players or imports with higher logistics costs.
Customer Relationships: Long-standing relationships with industrial clients, coupled with product customization capabilities, can create some switching costs for customers, though these are not extremely high in the commodity chemicals space.
Entry Barriers: The chemical manufacturing industry has high capital expenditure requirements and stringent regulatory and environmental compliance, acting as a deterrent for new entrants.
Growth Drivers
Key factors that can drive Manali Petrochemicals' growth over the next 3-5 years include:
Growth in End-User Industries: Strong demand from key sectors like automotive, construction, refrigeration, pharmaceuticals, and consumer goods, which are significant users of polyurethanes and PG derivatives.
Increasing Domestic Consumption: India's growing economy and rising disposable incomes are expected to boost consumption of products that utilize MPL's chemicals.
Infrastructure Development: Government thrust on infrastructure and housing directly impacts the demand for polyurethane-based insulation and other construction materials.
Expansion & Diversification: Any successful capacity expansion, debottlenecking, or diversification into higher-margin specialty chemicals could fuel growth.
Import Substitution: Opportunities arising from government initiatives encouraging domestic manufacturing and reducing reliance on imports.
Risks
Manali Petrochemicals faces several key business risks:
Raw Material Price Volatility: The prices of key raw materials like propylene and crude oil derivatives are highly volatile, directly impacting input costs and profitability.
Cyclicality of End-User Industries: Demand for its products is tied to the cyclical performance of sectors like automotive, construction, and consumer durables. A slowdown in these sectors can affect sales volumes and pricing.
Intense Competition: The company faces competition from both domestic players and international producers, leading to pricing pressures and margin erosion, especially during periods of oversupply.
Currency Fluctuations: As the company may import raw materials or export finished goods, adverse movements in foreign exchange rates can impact profitability.
Environmental & Regulatory Risks: Strict environmental regulations and the need for continuous compliance can lead to increased operational costs and potential penalties.
Technological Obsolescence: Rapid advancements in material science and chemical processes could render existing technologies less competitive over time.
Management & Ownership
Manali Petrochemicals Ltd. is part of the AM International Group (formerly MAC Group), a diversified conglomerate based in Chennai. The company is promoter-led, with Mr. Ashwin Muthiah serving as the Chairman. The management team generally consists of experienced professionals from the chemical industry. The ownership structure typically involves a significant promoter holding, alongside institutional investors and public shareholders. The promoter group has a long-standing presence in the Indian industrial landscape.
Outlook
Manali Petrochemicals operates in a foundational segment of the Indian chemicals industry, benefiting from the country's long-term growth trajectory in manufacturing, infrastructure, and consumption. Its established position as a domestic producer of PG and Polyols provides a stable base and competitive leverage against imports. The company's prospects are closely tied to the health and growth of its diverse end-user industries, which are expected to expand with India's economic development.
However, the company remains susceptible to the inherent cyclicality of the petrochemicals sector, particularly global raw material price volatility (crude oil derivatives) and intense competition. Managing input costs effectively, optimizing capacity utilization, and potentially diversifying into higher-value specialty chemicals will be crucial for sustained margin improvement. While enjoying domestic market advantages, its performance will reflect both India's industrial growth and global petrochemical market dynamics.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 205 | 256 | 240 | 230 | 196 | 230 | 235 | 248 | 247 | 293 |
| Other Income | 8 | 6 | 6 | 6 | 4 | 8 | 8 | 13 | 20 | 7 |
| Total Income | 212 | 263 | 247 | 236 | 200 | 238 | 243 | 261 | 267 | 299 |
| Total Expenditure | 200 | 239 | 220 | 226 | 183 | 209 | 212 | 228 | 233 | 268 |
| Operating Profit | 13 | 24 | 27 | 10 | 17 | 29 | 31 | 33 | 34 | 32 |
| Interest | 2 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 4 |
| Depreciation | 6 | 7 | 7 | 7 | 7 | 7 | 8 | 8 | 9 | 9 |
| Exceptional Income / Expenses | 0 | -6 | 0 | 0 | 0 | -3 | 0 | -1 | 51 | 19 |
| Profit Before Tax | 5 | 8 | 18 | 1 | 8 | 16 | 20 | 21 | 72 | 37 |
| Provision for Tax | 2 | 7 | 5 | 0 | 2 | 5 | 6 | 3 | 4 | 8 |
| Profit After Tax | 3 | 1 | 13 | 0 | 5 | 11 | 14 | 18 | 68 | 29 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 3 | 1 | 13 | 0 | 5 | 11 | 14 | 18 | 68 | 29 |
| Adjusted Earnings Per Share | 0.2 | 0.1 | 0.8 | 0 | 0.3 | 0.6 | 0.8 | 1.1 | 4 | 1.7 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 579 | 632 | 748 | 810 | 803 | 1024 | 1672 | 1177 | 1032 | 897 | 1023 |
| Other Income | 14 | 13 | 3 | 12 | 13 | 13 | 18 | 28 | 29 | 25 | 48 |
| Total Income | 593 | 645 | 751 | 822 | 816 | 1038 | 1690 | 1205 | 1062 | 922 | 1070 |
| Total Expenditure | 515 | 572 | 651 | 712 | 733 | 724 | 1143 | 1103 | 988 | 839 | 941 |
| Operating Profit | 77 | 73 | 100 | 110 | 83 | 314 | 547 | 102 | 74 | 83 | 130 |
| Interest | 3 | 2 | 3 | 2 | 6 | 5 | 9 | 9 | 10 | 10 | 13 |
| Depreciation | 6 | 10 | 9 | 11 | 14 | 21 | 20 | 23 | 25 | 27 | 34 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 17 | -8 | -21 | -7 | 0 | -6 | -3 | 69 |
| Profit Before Tax | 69 | 61 | 88 | 113 | 54 | 268 | 511 | 70 | 33 | 42 | 150 |
| Provision for Tax | 21 | 22 | 30 | 37 | 8 | 67 | 129 | 19 | 14 | 13 | 21 |
| Profit After Tax | 48 | 40 | 58 | 77 | 47 | 201 | 381 | 51 | 19 | 29 | 129 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 48 | 40 | 58 | 77 | 47 | 201 | 381 | 51 | 19 | 29 | 129 |
| Adjusted Earnings Per Share | 2.8 | 2.3 | 3.4 | 4.5 | 2.7 | 11.7 | 22.2 | 2.9 | 1.1 | 1.7 | 7.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -13% | -19% | 2% | 0% |
| Operating Profit CAGR | 12% | -47% | 0% | 0% |
| PAT CAGR | 53% | -58% | -9% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 2% | -0% | -4% | 8% |
| ROE Average | 3% | 3% | 18% | 16% |
| ROCE Average | 5% | 5% | 24% | 23% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 282 | 330 | 392 | 455 | 481 | 680 | 1030 | 1044 | 1062 | 1094 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19 |
| Other Non-Current Liabilities | 5 | 16 | 25 | 30 | 53 | 43 | 75 | 83 | 84 | 80 |
| Total Current Liabilities | 234 | 210 | 139 | 169 | 126 | 169 | 185 | 147 | 163 | 209 |
| Total Liabilities | 522 | 556 | 556 | 654 | 660 | 892 | 1290 | 1274 | 1308 | 1403 |
| Fixed Assets | 105 | 234 | 273 | 283 | 302 | 292 | 343 | 552 | 559 | 596 |
| Other Non-Current Assets | 39 | 49 | 33 | 29 | 47 | 51 | 39 | 48 | 48 | 115 |
| Total Current Assets | 377 | 273 | 250 | 342 | 310 | 550 | 908 | 674 | 701 | 692 |
| Total Assets | 522 | 556 | 556 | 654 | 660 | 892 | 1290 | 1274 | 1308 | 1403 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 94 | 70 | 30 | 63 | 54 | 95 | 282 | 612 | 378 | 364 |
| Cash Flow from Operating Activities | -6 | 87 | 58 | 13 | 87 | 219 | 373 | 92 | 75 | -19 |
| Cash Flow from Investing Activities | -7 | -124 | -22 | -17 | -21 | -15 | -13 | -267 | -82 | -155 |
| Cash Flow from Financing Activities | -11 | 6 | -17 | -2 | -29 | -28 | -26 | -64 | -7 | -0 |
| Net Cash Inflow / Outflow | -24 | -31 | 19 | -6 | 38 | 176 | 334 | -239 | -14 | -174 |
| Closing Cash & Cash Equivalent | 70 | 30 | 63 | 54 | 95 | 282 | 612 | 378 | 364 | 190 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 2.79 | 2.3 | 3.37 | 4.45 | 2.71 | 11.7 | 22.16 | 2.95 | 1.12 | 1.7 |
| CEPS(Rs) | 3.13 | 2.86 | 3.88 | 5.1 | 3.55 | 12.92 | 23.32 | 4.29 | 2.59 | 3.28 |
| DPS(Rs) | 0.5 | 0.5 | 0.5 | 0.75 | 0.75 | 1.5 | 2.5 | 0.75 | 0.75 | 0.5 |
| Book NAV/Share(Rs) | 16.42 | 19.2 | 22.77 | 26.45 | 27.98 | 39.53 | 59.91 | 60.72 | 61.73 | 63.63 |
| Core EBITDA Margin(%) | 9.75 | 8.59 | 12.34 | 11.87 | 8.51 | 29.07 | 31.4 | 6.23 | 4.28 | 6.42 |
| EBIT Margin(%) | 10.93 | 9.09 | 11.58 | 13.94 | 7.35 | 26.34 | 30.88 | 6.64 | 4.12 | 5.78 |
| Pre Tax Margin(%) | 10.54 | 8.76 | 11.17 | 13.66 | 6.59 | 25.88 | 30.32 | 5.86 | 3.2 | 4.63 |
| PAT Margin (%) | 7.33 | 5.66 | 7.37 | 9.22 | 5.67 | 19.45 | 22.63 | 4.25 | 1.84 | 3.23 |
| Cash Profit Margin (%) | 8.22 | 7.04 | 8.5 | 10.55 | 7.43 | 21.48 | 23.82 | 6.19 | 4.27 | 6.21 |
| ROA(%) | 9.19 | 7.34 | 10.41 | 12.66 | 7.1 | 25.93 | 34.93 | 3.95 | 1.49 | 2.16 |
| ROE(%) | 16.98 | 12.91 | 16.04 | 18.09 | 9.97 | 34.66 | 44.56 | 4.88 | 1.82 | 2.72 |
| ROCE(%) | 25.12 | 19.82 | 23.61 | 25.64 | 12.15 | 45.38 | 59.64 | 7.54 | 4.02 | 4.72 |
| Receivable days | 50.2 | 46.45 | 43.86 | 47.29 | 49.37 | 49.44 | 35.78 | 48.57 | 49.09 | 47.85 |
| Inventory Days | 58.25 | 59.68 | 45.62 | 41.83 | 45.87 | 28.08 | 17.13 | 30.06 | 38.03 | 61.13 |
| Payable days | 100.15 | 93.98 | 69.47 | 54.31 | 48.34 | 45.41 | 35.31 | 34.01 | 31.03 | 50.22 |
| PER(x) | 9 | 17.37 | 9.95 | 5.69 | 3.72 | 5.07 | 4.89 | 20.41 | 50.32 | 32.97 |
| Price/Book(x) | 1.53 | 2.08 | 1.47 | 0.96 | 0.36 | 1.5 | 1.81 | 0.99 | 0.91 | 0.88 |
| Dividend Yield(%) | 1.99 | 1.25 | 1.49 | 2.96 | 7.43 | 2.53 | 2.31 | 1.25 | 1.33 | 0.89 |
| EV/Net Sales(x) | 0.73 | 1.08 | 0.79 | 0.5 | 0.17 | 0.73 | 0.76 | 0.56 | 0.55 | 0.76 |
| EV/Core EBITDA(x) | 5.47 | 9.36 | 5.87 | 3.71 | 1.68 | 2.38 | 2.32 | 6.41 | 7.68 | 8.2 |
| Net Sales Growth(%) | 0 | 9.16 | 18.31 | 8.35 | -0.89 | 27.57 | 63.2 | -29.6 | -12.3 | -13.1 |
| EBIT Growth(%) | 0 | -11.16 | 43.28 | 27.2 | -47.79 | 350.7 | 90.75 | -84.77 | -45.76 | 22.24 |
| PAT Growth(%) | 0 | -17.51 | 46.38 | 32.29 | -39.08 | 331.3 | 89.38 | -86.71 | -62.08 | 52.58 |
| EPS Growth(%) | 0 | -17.51 | 46.38 | 32.28 | -39.09 | 331.31 | 89.38 | -86.71 | -62.08 | 52.57 |
| Debt/Equity(x) | 0.01 | 0.08 | 0.06 | 0.07 | 0.05 | 0.02 | 0.02 | 0.01 | 0.02 | 0.04 |
| Current Ratio(x) | 1.61 | 1.3 | 1.8 | 2.03 | 2.46 | 3.25 | 4.92 | 4.6 | 4.31 | 3.31 |
| Quick Ratio(x) | 1.16 | 0.71 | 1.28 | 1.33 | 1.75 | 2.83 | 4.44 | 3.85 | 3.64 | 2.38 |
| Interest Cover(x) | 28.35 | 27.47 | 27.97 | 49.82 | 9.66 | 57.92 | 55.84 | 8.59 | 4.47 | 5.02 |
| Total Debt/Mcap(x) | 0.01 | 0.04 | 0.04 | 0.08 | 0.15 | 0.01 | 0.01 | 0.01 | 0.02 | 0.05 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 44.86 | 44.86 | 44.86 | 44.86 | 44.86 | 44.86 | 44.86 | 44.86 | 44.86 | 44.86 |
| FII | 0.86 | 0.79 | 1.32 | 1.11 | 1.06 | 0.66 | 0.45 | 0.44 | 0.29 | 0.37 |
| DII | 0.02 | 0.02 | 0.07 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 54.26 | 54.33 | 53.75 | 54.01 | 54.07 | 54.47 | 54.67 | 54.69 | 54.83 | 54.76 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 7.72 | 7.72 | 7.72 | 7.72 | 7.72 | 7.72 | 7.72 | 7.72 | 7.72 | 7.72 |
| FII | 0.15 | 0.14 | 0.23 | 0.19 | 0.18 | 0.11 | 0.08 | 0.08 | 0.05 | 0.06 |
| DII | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 9.33 | 9.34 | 9.24 | 9.29 | 9.3 | 9.37 | 9.4 | 9.41 | 9.43 | 9.42 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17.2 | 17.2 | 17.2 | 17.2 | 17.2 | 17.2 | 17.2 | 17.2 | 17.2 | 17.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -13% | -19% | +2% | — |
| Operating Profit CAGR | +12% | -47% | 0% | — |
| PAT CAGR | +53% | -58% | -9% | — |
| Share Price CAGR | +2% | 0% | -4% | +8% |
| ROE Average | +3% | +3% | +18% | +16% |
| ROCE Average | +5% | +5% | +24% | +23% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 44.86 | 44.86 | 44.86 | 44.86 | 44.86 | 44.86 | 44.86 | 44.86 | 44.86 | 44.86 |
| FII | 0.86 | 0.79 | 1.32 | 1.11 | 1.06 | 0.66 | 0.45 | 0.44 | 0.29 | 0.37 |
| DII | 0.02 | 0.02 | 0.07 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 55.14 | 55.14 | 55.14 | 55.14 | 55.14 | 55.14 | 55.14 | 55.14 | 55.14 | 55.14 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 7.72 | 7.72 | 7.72 | 7.72 | 7.72 | 7.72 | 7.72 | 7.72 | 7.72 | 7.72 |
| FII | 0.15 | 0.14 | 0.23 | 0.19 | 0.18 | 0.11 | 0.08 | 0.08 | 0.05 | 0.06 |
| DII | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 9.48 | 9.48 | 9.48 | 9.48 | 9.48 | 9.48 | 9.48 | 9.48 | 9.48 | 9.48 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17.2 | 17.2 | 17.2 | 17.2 | 17.2 | 17.2 | 17.2 | 17.2 | 17.2 | 17.2 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.